3-aminophenoxazone has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazawa, K; Tabuchi, T; Tomoda, A | 1 |
| Che, XF; Konishi, M; Miyazawa, K; Nagata, H; Tabuchi, T; Tomoda, A; Ubukata, H | 1 |
1 review(s) available for 3-aminophenoxazone and Stomach Neoplasms
| Article | Year |
|---|---|
Prevention of carcinogenesis and development of gastric and colon cancers by 2-aminophenoxazine-3-one (Phx-3): direct and indirect anti-cancer activity of Phx-3.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogenesis; Colonic Neoplasms; Humans; Oxazines; Stomach Neoplasms | 2013 |
1 other study(ies) available for 3-aminophenoxazone and Stomach Neoplasms
| Article | Year |
|---|---|
Rapid decrease of intracellular pH associated with inhibition of Na+/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intracellular Space; Models, Biological; Oxazines; Sodium-Hydrogen Exchangers; Stomach Neoplasms; Time Factors | 2011 |